Radioiodine-refractory thyroid cancer: a complex challenge
Minerva Med
.
2021 Dec;112(6):686-688.
doi: 10.23736/S0026-4806.21.07845-9.
Epub 2021 Oct 21.
Authors
Giovanni Vitale
1
2
,
Giuseppe Pellegrino
3
,
Elio Desiderio
4
,
Luigi Barrea
5
6
Affiliations
1
Laboratory of Geriatric and Oncologic Neuroendocrinology Research, Istituto Auxologico Italiano IRCCS, Cusano Milanino, Milan, Italy - giovanni.vitale@unimi.it.
2
Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy - giovanni.vitale@unimi.it.
3
Postgraduation School in Radiodiagnostics, University of Milan, Milan, Italy.
4
Faculty of Medicine, University of Naples Federico II, Naples, Italy.
5
Dipartimento di Scienze Umanistiche, Università Telematica Pegaso, Naples, Italy.
6
Centro Italiano per la Cura e il Benessere del Paziente con Obesità (C.I.B.O.), University of Naples Federico II, Naples, Italy.
PMID:
34672171
DOI:
10.23736/S0026-4806.21.07845-9
No abstract available
Publication types
Editorial
MeSH terms
Humans
Iodine Radioisotopes / therapeutic use*
Thyroid Neoplasms / radiotherapy*
Treatment Failure
Substances
Iodine Radioisotopes